Cell-Free DNA Methylation Predicts Chemo Benefit in Bladder Cancer
Methylation patterns in cfDNA from blood samples can help predict which patients with a type of bladder cancer may benefit from chemotherapy.
Methylation patterns in cfDNA from blood samples can help predict which patients with a type of bladder cancer may benefit from chemotherapy.
Delfi Diagnostics has entered into a broad research agreement with Memorial Sloan Kettering Cancer Center's Biomarker Development Program.
The ASCO has expanded the utility of BCI in its guideline: “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.”
A new way of using AI to predict cancer from patient data without putting personal information at risk has been developed.
Read MoreResearchers have developed a new urine test for bladder cancer, which could significantly cut the need for invasive cystoscopies.
Read MoreAI reduced the rate at which precancerous polyps were missed in colorectal cancer screening by twofold, according to new research.
Read MoreNew data has shown that a tsRNA named tRF-Gln-TTG-006 in liver cancer patients’ serum may be a promising biomarker to detect liver cancer.
Read MoreThis study validated the clinical utility of a DCIS test to predict recurrence risk and radiation therapy benefit in certain patients
Read MoreResearchers have developed a PCR test for mouth cancer, which only requires machines used in COVID testing and a technician to operate it.
Read MorePSA screening for prostate cancer could be improved by accounting for genetic factors that cause PSA changes not associated with cancer.
Read MoreResearch has provided more clues on the origins and progression of certain blood cancers, suggesting new ways to diagnose and treat leukemias.
Read MoreResearchers found a process to study the actions of circulating tumor cells responsible for cancer recurrence of non-small cell lung cancer.
Read MoreGuardant Health partnered with Epic, a health record company, to integrate the oncology company’s portfolio of cancer tests with its services.
Read MoreProteins could one day allow breast cancer screenings to be done via blood test thanks to new biomarkers identified in breast milk.
Read MoreLiquid biopsy performed on serum samples from breast cancer patients can provide increasingly accurate information on cancer progression.
Read MoreKinetic River has been awarded a Phase II SBIR grant for the development of an autofluorescence-free flow cytometry platform.
Read MorePaige, has launched its Paige Breast Lymph Node, an AI software that helps detect if breast cancer has metastasized to lymph nodes.
Read MoreThe study aims to enables access to comprehensive genetic and genomic testing for advanced cancer patients in underserved communities.
Read More